TELA Bio amends 8-K to detail former CEO Koblish separation benefits - TELA News | RalliesTELA Bio amends 8-K to detail former CEO Koblish separation benefits
T
TELA• Amended 8-K details Koblish separation agreement
- TELA Bio amended a prior 8-K to add details of a separation agreement with former CEO Antony Koblish, effective Aug. 7.
- The agreement provides 12 months of base-salary severance, paid in installments, covering the period following his Aug. 3 exit.
- All equity awards immediately accelerated to full vesting; the option exercise window was extended to the earlier of Dec. 31, 2027 or expiry.
- COBRA coverage is available through Aug. 31; the company will pay premiums for 12 months if elected by Sept. 1.
- Performance stock units remain eligible to vest through Dec. 31, 2026, with target vesting on a change in control by then.
EMAT
•
